Lamendola Damien

CEO Damien Lamendola buys 147,058 shares of MRAI at $1.36 (Sept 30), expanding stake to 6.42M shares as company faces -24.2% revenue decline and $4.4M net loss.

Lamendola purchased 147,058 shares for $200.0K at $1.36 on 2025-09-30, expanding his holdings to 6.42M shares. This marks his third buy in 21 days at MRAI, following purchases on 2025-09-10 and 2025-07-29. At the company level, fundamentals show stress: latest quarterly revenue of $4.7M represents -24.2% annual revenue growth, and the company recorded a net loss of $4.4M over its most recent full fiscal year. The stock currently trades at $1.44, +4.4% over 30 days but -12.2% from its 52-week high. Among his prior trades at this ticker, timing has been mixed (1 of 2 measurable 90-day outcomes well-timed, including a +199.4% return on his 2024-08-28 buy), but recent prior-trade outcomes at this specific ticker show outsized 30-day gains (+28.2%, +25.0% on the July purchases). The rapid accumulation cadence and positive interim price movement on recent purchases merit monitoring against the backdrop of deteriorating company-level revenue and profitability metrics.

CEO Lamendola buys 896.9K MRAI shares for $950.0K at $1.06 amid -20.0% 30-day decline; mixed timing record on this ticker.

Lamendola purchased 896,903 shares at $1.06, raising his holdings to 6,272,835 shares (+16.7% vs prior holdings). The purchase occurs while MRAI shares have declined 20.0% over the past 30 days and sit 32.9% below the 52-week high of $1.64, presenting a lower entry point relative to recent performance. Examining his same-ticker history at MRAI: two recent buys on 2025-07-29 and 2025-07-17 posted gains of 28.2% and 25.0% over 30 days respectively, but earlier trades at this ticker showed mixed outcomes (one 90-day win of 199.4%, offset by 90-day losses of -75.9% and -44.8%), with only 1 of 3 prior buys well-timed at the 90-day mark. Fundamentals remain challenged: the company reported negative net income of -4.4M on quarterly revenue of 4.7M, with full-year revenue declining 24.2% year-over-year and an 18.0M market cap, suggesting structural headwinds that may weigh on near-term outcomes despite recent intra-quarter momentum.

MRAI CEO Lamendola buys 371,470 shares at $1.08 on 2025-07-29; 12 days after prior buy at same price.

Damien Lamendola, Chief Executive Officer of Marpai, Inc., purchased 371,470 shares at $1.08 on 2025-07-29, investing $399,998.90 to increase his holdings from 5,004,462 to 5,375,932 shares (+7.4%). This buy occurred just 12 days after his previous purchase on 2025-07-17 at the same price level ($1.08). The current price of $1.19 sits -27.4% below the 52-week high and has declined -13.8% over the past 30 days, despite a +13.3% gain over 90 days. Notably, Marpai reported negative net income of $-3,069,000.00 in its latest quarter and -24.2% annual revenue decline, with a market cap of only $17,727,056.34. His prior trades at MRAI show mixed results: 2 of 4 measurable same-ticker buys exhibited positive 90-day returns (those on 2024-08-28 returning +199.4% and 2024-01-16 returning +122.8%), while the others turned negative. The consecutive purchases at identical prices, combined with the company's unprofitable fundamentals and recent price weakness, warrant investor scrutiny of whether the CEO perceives value or is meeting predetermined accumulation targets.

CEO Damien Lamendola purchases 86,805 shares of MRAI at $1.15 for $99,999.36; holdings rise to 5,004,462 shares as stock trades 18.3% below 52-week high

Damien Lamendola, as Chief Executive Officer, purchased 86,805 shares at $1.15 on 2025-07-17, bringing his total holdings to 5,004,462 shares. The transaction occurred at a price 14.2% below the current market price of $1.34 and represents accumulation within a 52-week range of $0.43–$1.64, currently 18.3% from the high. His prior trading activity at MRAI shows mixed timing outcomes: 3 of 5 prior buys were well-timed at the 90-day mark, though the most recent buy on 2024-08-28 achieved +20.6% 30-day and +199.4% 90-day returns while the 2024-05-10 purchase resulted in -66.7% 30-day and -75.9% 90-day returns. The underlying company reported net income of $-3.1M against $5.4M revenue in the latest quarter, with annual revenue declining 24.2% year-over-year; the company remains unprofitable on a full-year basis. The CEO's willingness to deploy capital at $1.15 into a loss-making business with contracting revenues occurs alongside a recent 90-day appreciation of +39.6%, which may signal either conviction in a turnaround or a discretionary allocation decision in a volatile micro-cap environment.

MRAI CEO Damien Lamendola buys 1,351,351 shares at $0.48 (total $649,999.83); holdings up 37.9% to 4.92M shares

Lamendola purchased 1,351,351 shares of Marpai at $0.48 on 2024-08-28, increasing his position from 3.57M to 4.92M shares—a material 37.9% stake expansion. At his prior trades at MRAI, the insider demonstrated a mixed record: 3 of 5 prior buys achieved positive 90-day returns (well-timed at the 90-day mark), most notably a January 2024 buy that returned +122.8% over 90 days, but offset by recent underperformance (May 2024 buy down 75.9% at 90 days). The current price of $0.60 represents a -78.6% decline from the 52-week high of $2.81, suggesting the purchase price of $0.48 captured a deeply depressed valuation relative to recent trading. Meanwhile, the company reported $7.2M quarterly revenue with +52.6% annual growth but remains unprofitable with $-13.0M net income and a market cap of only $6.6M—a micro-cap with acute cash burn relative to revenue scale. This concentrated insider accumulation at a depressed price amid severe unprofitability and recent stock weakness warrants examination of whether cash position, burn rate, or financing contingencies are driving both the insider's conviction and the market's repricing.